A new study explores the use of liver biopsy to differentiate drug-induced liver injury (DILI) from autoimmune hepatitis. However, not all that glitters is necessarily the gold standard—disagreement among experts on the histological features of DILI could create uncertainty over the accuracy of this diagnostic approach.
